IGF-I levels and visceral fat accumulation in colonic neoplasia

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 1, 2014, Pages 99-105

  Erarslan, Elife ^a   Coşkun, Yusuf ^a   Türkay, Cansel ^b   Köktener, Asli ^b   Aydoǧan, Timuçin ^c  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED;

EID: 84893904110     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.06.004     Document Type: Article

References (43)

1. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. American Institute for Cancer Research 11th annual research conference on diet, nutrition and cancer. J Nutr 2001, 131:S3109-S3120.
2. Tran T.T., Naigamwalla D., Oprescu A.I., et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutelyenhances colorectal epithelial proliferation in vivo. Endocrinology 2006, 147:1830-1837.
3. Giovannucci E., Pollak M.N., Platz E.A., et al. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000, 9:345-349.
4. Ma J., Pollak M.N., Giovannucci E., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF binding protein-3. J Natl Cancer Inst 1999, 91:620-625.
5. Burke C.A. Colonic complications of obesity. Gastroenterol Clin North Am 2010, 39(1):47-55.
6. Von Hafe P., Pina F., Pérez A., et al. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004, 12:1930-1935.
7. Schoen R.E., Tangen C.M., Kuller L.H., et al. Increased blood glucose and insulin, body size, and indent colorectal cancer. J Natl Cancer Inst 1999, 91:1147-1154.
8. Guo Y.S., Narayan S., Yallampalli C., et al. Characterization of insulin-like growth factor-I receptors in human colon cancer. Gastroenterology 1992, 102:1101-1108.
9. Cats A., Dullaart R., Kleibeuker J., et al. Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 1996, 56:523-526.
10. Jenkins P.J., Fairclough P., Richards T., et al. Acromegaly, colonic polyps and carcinoma. Clin Endocrinol 1997, 47:17-22.
11. Warren R., Yuan H., Matli M., et al. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 1996, 271:29483-29488.
12. Manjinder S., Sandhu D.B., Dunger E.L., et al. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002, 94(13):972-980.
13. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (Washington DC) 1998, 279:563-566.
14. Nieves D.J., Cnop M., Retzlaff B., et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003, 52:172-179.
15. Fujita K., Nishizawa H., Funahashi T., et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006, 70:1437-1442.
16. Kern P.A., Di Gregorio G.B., Lu T., et al. Adiponectin expression from human adipose tissue relation to obesity, insulin resistance, and tumor necrosis factor-expression. Diabetes 2003, 52:1779-1785.
17. Saiki A., Miyashita Y., Wakabayashi M., et al. Reduction of visceral adiposity after operation in a subject with insulinoma. J Atheroscler Thromb 2004, 11(4):209-214.
18. Ealey K.N., Archer M.C. Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int J Cancer 2009, 124(9):2226-2230.
19. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995, 6:164-179.
20. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?. Cancer Epidemiol Biomarkers Prev 1994, 3:687-695.
21. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
22. Seidell J.C., Oosterlee A., Thijssen M.A., et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr 1987, 45:7-13.
23. Schoen R.E., Weissfeld J.L., Kuller L.H., et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005, 129(2):464-475.
24. Renehan A.G., Painter J.E., Atkin W.S., et al. High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 2001, 88(1):107-113.
25. Boyd D.B. Insulin and cancer. Integr Cancer Ther 2003, 2(4):315-329.
26. Renehan A.G., Painter J.E., O'Halloran D., et al. Circulating insulin-like growth factor-II and colorectal adenomas. J Clin Endocrinol Metab 2000, 85:3402-3408.
27. Palmqvist R., Hallmans G., Rinaldi S., et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein-3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002, 50:642-646.
28. Jenkins P.J., Frajese V., Jones A.M., et al. Insulin-like growth factor-I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000, 85(9):3218-3221.
29. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
30. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000, 183:1-9.
31. Wu X., Yu H., Amos C.I., Hong W.K., Spitz M.R. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 2000, 92:737-743.
32. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000, 92:1472-1489.
33. Mac Innis R.J., English D.R., Hopper J.L., et al. Body size and composition and colon cancer risk in women. Int J Cancer 2006, 118:1496-1500.
34. Nishii T., Kono S., Abe H., et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese. Jpn J Cancer Res 2001, 92:836-840.
35. Otake S., Takeda H., Suzuki Y., et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005, 11:3642-3646.
36. Schoen R.E., Schragin J., Weissfeld J.L., et al. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiol Biomarkers Prev 2002, 11(6):581-586.
37. Kunitomi M., Wada J., Takahashi K., et al. Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men. Int J Obes 2002, 26:361-369.
38. Limburg P.J., Stolzenberg-Solomon R.Z., Vierkant R.A., et al. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 2006, 4:1514-1521.
39. Saydah S.H., Platz E.A., Rifai N., et al. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003, 12:412-418.
40. Palmqvist R., Stattin P., Rinaldi S., et al. Plasma insulin, IGF binding proteins-1 and -2 and risk of colorectal cancer: a prospective studyin northern Sweden. Int J Cancer 2003, 107:89-93.
41. Lukanova A., Söderberg S., Stattin P., et al. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF binding protein-3 ratio with indices of adiposity and plasma insulin concentrations. Cancer Causes Control 2002, 13(6):509-516.
42. Wei E.K., Giovannucci E., Fuchs C.S., et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005, 97(22):1688-1694.
43. Murphy T.K., Calle E.E., Rodriguez C., et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000, 152(9):847-854.